MPO and Autoimmunity: Collectively, these data strongly indicate that rhDNase I inhibits the development of anti-MPO autoimmunity by reducing the frequency of Th1 MPO-specific effector cells while increasing the frequency of MPO-specific Tregs with increased capacity to respond to MPO.